Literature DB >> 17460118

Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.

So-Hee Kim1, Seung-Young Hwang, Yong-Seok Lee, In-Hak Choi, Sae-Gwang Park, Weon-Gyu Kho.   

Abstract

Phage display of single-chain variable fragment (scFv) antibodies is a powerful tool for selecting important, useful, and specific human antibodies. We constructed a library from three patients infected with Plasmodium vivax. Panning on recombinant PvRII enriched a population of scFvs that recognized region II of the P. vivax Duffy binding protein (DBP). Three clones of scFvs that reacted with PvRII were selected, and their biological functions were analyzed. These scFvs inhibited erythrocyte binding to DBP. Clone SFDBII92 had the greatest affinity (dissociation constant = 3.62 x 10(-8) M) and the greatest inhibition activity (50% inhibitory concentration approximately 2.9 microg/ml) to DBP. Thus, we demonstrated that human neutralizing antibody could be made from malaria patients using phage display and that these neutralizing scFvs should prove valuable for developing both passive and active immunization strategies based on DBP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460118      PMCID: PMC1951088          DOI: 10.1128/CVI.00456-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1.

Authors:  K M Sowa; D R Cavanagh; A M Creasey; J Raats; J McBride; R Sauerwein; W F Roeffen; D E Arnot
Journal:  Mol Biochem Parasitol       Date:  2001-01-15       Impact factor: 1.759

2.  Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum.

Authors:  W F Roeffen; J M Raats; K Teelen; R M Hoet; W M Eling; W J van Venrooij; R W Sauerwein
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

3.  Analysis of polymorphic regions of Plasmodium vivax Duffy binding protein of Korean isolates.

Authors:  W G Kho; J Y Chung; E J Sim; D W Kim; W C Chung
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

4.  Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins.

Authors:  A Ranjan; C E Chitnis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 5.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

6.  Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.

Authors:  P Michon; T Fraser; J H Adams
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties.

Authors:  Rasmus Lundquist; Leif Kofoed Nielsen; Ali Jafarshad; Daw Soesoe; Lars Harder Christensen; Pierre Druilhe; Morten Hanefeld Dziegiel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

8.  Affinity maturation of natural antibody using a chain shuffling technique and the expression of recombinant antibodies in Escherichia coli.

Authors:  S G Park; J S Lee; E Y Je; I J Kim; J H Chung; I H Choi
Journal:  Biochem Biophys Res Commun       Date:  2000-08-28       Impact factor: 3.575

9.  Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion.

Authors:  Saurabh K Singh; Agam P Singh; Sunita Pandey; Syed S Yazdani; Chetan E Chitnis; Amit Sharma
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  The erythrocyte binding motif of plasmodium vivax duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea.

Authors:  J Xainli; J H Adams; C L King
Journal:  Mol Biochem Parasitol       Date:  2000-12       Impact factor: 1.759

View more
  5 in total

1.  Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein.

Authors:  Lenore L Carias; Sebastien Dechavanne; Vanessa C Nicolete; Sokunthea Sreng; Seila Suon; Chanaki Amaratunga; Rick M Fairhurst; Celia Dechavanne; Samantha Barnes; Benoit Witkowski; Jean Popovici; Camille Roesch; Edwin Chen; Marcelo U Ferreira; Niraj H Tolia; John H Adams; Christopher L King
Journal:  J Immunol       Date:  2019-04-03       Impact factor: 5.422

2.  Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10.

Authors:  Dominika J Maskus; Susanne Bethke; Melanie Seidel; Stephanie Kapelski; Otchere Addai-Mensah; Alexander Boes; Güven Edgü; Holger Spiegel; Andreas Reimann; Rainer Fischer; Stefan Barth; Torsten Klockenbring; Rolf Fendel
Journal:  Malar J       Date:  2015-07-16       Impact factor: 2.979

3.  Diversity and evolutionary genetics of the three major Plasmodium vivax merozoite genes participating in reticulocyte invasion in southern Mexico.

Authors:  Lilia González-Cerón; Rene Cerritos; Jordán Corzo-Mancilla; Frida Santillán
Journal:  Parasit Vectors       Date:  2015-12-21       Impact factor: 3.876

4.  Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.

Authors:  R R Tonelli; W Colli; M J M Alves
Journal:  Front Immunol       Date:  2013-01-09       Impact factor: 7.561

Review 5.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.